This is Archived Content

This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). Find the latest information on substance use, health, and NIDA research at

Based on the FY 2010 appropriation, the National Institute on Drug Abuse (NIDA) has established the following funding policy for non-ARRA related projects.

NIDA will continue to support the:


The FY 2010 average cost of competing grants is allowed to increase by 2% over FY 2009.

Non-Competing Continuations (Type 5)

  • All non-competing continuations (modular and non-modular) will be funded at 99% of committed levels, including co-funds. This policy does not apply to F's, T's, K's, SBIR/STTR and R13s. Future commitments will be adjusted accordingly.
  • Information regarding the NIH Fiscal Policy for Grant Awards - FY 2010 can be found at

New and Early Stage Investigators

Ruth L. Kirschstein National Research Service Awards (NRSA)

  • NIDA will support a 1% increase at all stipend levels